Sybilla Technologies Raises $9.3M Seed Round

Vestbee

Vestbee is one of the leading platforms empowering startup founders, VC funds, angels, accelerators and corporates with the right community, infrastructure, and tools to succeed.

Infermedica

Infermedica is a global health tech company established in 2012. Its certified AI Triage tools provide accurate and efficient care navigation to patients and members by helping them understand their symptoms and navigate complex healthcare systems to find the right level of care at the right time. Used by over 100 organizations in more than 35 countries and 26 languages, Infermedica’s symptom checker has performed more than 27 million health checkups to date. Infermedica tools are developed and maintained by a team of over 40 doctors, who have contributed over 155,000 physician work hours to ensure medical accuracy. Infermedica modules are MDR Class IIb certified Medical Devices in the EU and compliant with HIPAA and GDPR standards. Find out more at infermedica.com. Privacy policy: https://infermedica.com/privacy-policy

Billon

Billon Unified Blockchain A high-performance, regulatory-compliant blockchain for on-chain document and data exchange, asset tokenization, and digital cash secured by user controlled sovereign identity. Billon created a DLT protocol and system for national currency payments and document storage at scale, meeting all regulatory requirements and solving challenges for the wide adoption of blockchain technologies. With the protocol designed for high throughput and low cost of maintenance, our mission is to unleash the transformational capabilities of blockchain in the regulated world. Billon provides client services for handling documents and regulated e-money on blockchain. The system also supports clients developing their own enterprise solutions in areas of Trusted Document Management, Regulated Digital Cash and Asset & Data Tokenization Billon Group Ltd. was founded in the UK in 2015, following several years of R&D in Poland. Its unique DLT protocol has been supported by many R&D grants, including the EU Horizon 2020 program. Billon subsidiary companies are licensed to issue electronic money by regulators in the UK and Poland. Billon’s growing partner list includes leading companies such as FIS, Raiffeisen Bank International and BIK (the Polish credit reporting agency). Billon has offices in London and Warsaw. www.billongroup.com.

BAAS

Personal counseling, selection and recruitment of staff. Business consulting. The implementation of nanotechnologies in road construction.

Noctiluca (international page)

Noctiluca is a technology company that develops and produces high-performance chemical compounds for diverse applications. We develop and produce chemical compounds for OLED displays, printed electronics, digital signage, lighting, organic photovoltaics and more. We also offer a comprehensive range of chemical services, including research and development (R&D). CHEMICAL CONTRACT RESEARCH ORGANIZATION In addition to developing chemical compounds for products of the future, we are a Chemical CRO. We conduct R&D research on behalf of our Partners. Our scientific team undertakes projects in the chemical industry to develop cutting-edge solutions, primarily focusing on high-performance materials (HPMs). CUSTOM SYNTHESIS We produce chemical compounds. Our experience includes mainly the production of organic compounds for applications in optoelectronics and related fields. We also perform syntheses of, among others, high-purity organic compounds of gallium, zirconium, tin and indium for ALD and CVD applications, and Gratzl-type dyes for DSSC applications. SUBLIMATION With our specialized knowledge and resources, we can efficiently scale the sublimation process for your compounds to meet the demands of a semi-industrial operation. Rest assured that our commitment to precision and quality ensures the creation of the highest caliber products. Noctiluca is listed on the Main Market of the Warsaw Stock Exchange.